Andrew Wei is a Clinical Haematologist, current National Health and Medical Research Council (NHMRC) Clinical Fellow and Co-lead for acute leukaemia program at the Peter MacCallum Centre and the Royal Melbourne Hospital in Melbourne, Australia. He holds a joint appointment as the Metcalf Family Fellow and a laboratory head in the division of Blood Cells and Blood Cancer at the Walter and Eliza Hall Institute of Medical Research (WEHI). Andrew Wei has served for more than a decade as chair of the acute leukaemia and myelodysplastic syndrome working party for the Australasian Leukaemia and Lymphoma Group. He is an internationally recognised expert in the field of acute myeloid leukaemia (AML) and has led several clinical trial programs that have contributed to regulatory drug approval and change in clinical practice. He has mentored clinical fellows to develop AML trials for over a decade and his laboratory at WEHI has studied the activity of novel drugs and mechanisms of resistance in acute myeloid leukaemia. He has authored more than 200 peer reviewed publications, predominantly in the field of AML and has more than 13,000 literature citations.
Lab Website:Â https://www.wehi.edu.au/researcher/andrew-wei/